Clinical Trial Update: Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Ranquilon for anxiety disorders due to neurasthenia and adjustment disorders is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adjustment Disorders
• Anxiety Disorders
• Neurasthenia

Drugs mentioned

• Ranquilon

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Anxiety, Neurasthenia | Phase 4 | Status: RECRUITING